Calculating cardiac risk in obese adolescents before and after onset of lifestyle intervention

Expert Review of Cardiovascular Therapy

Volumn 11, Issue 3, 2013, Pages 297-306

  Reinehr, Thomas ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

cardiovascular risk factors; dyslipidemia; hypertension; impaired glucose tolerance; intima media thickness; metabolic syndrome

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADOLESCENT DISEASE; AGE DISTRIBUTION; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BODY FAT DISTRIBUTION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DYSLIPIDEMIA; FAT MASS; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; IMAGE ANALYSIS; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INTRA ABDOMINAL ADIPOSE TISSUE; LIFESTYLE MODIFICATION; LONGITUDINAL STUDY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; REVIEW; SCREENING TEST; SEX DIFFERENCE; THROMBOSIS; VASCULARIZATION; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADIPOKINES; ADOLESCENT; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; HUMANS; INTRA-ABDOMINAL FAT; LIFE STYLE; OBESITY; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; WEIGHT LOSS;

EID: 84874869112     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.13.6     Document Type: Review

References (128)

1. Han JC, Lawlor DA, Kimm SY. Childhood obesity. Lancet 375(9727), 1737-1748 (2010).
2. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N. Engl. J. Med. 337(13), 869-873 (1997).
3. Baker JL, Olsen LW, Sørensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N. Engl. J. Med. 357(23), 2329-2337 (2007).
4. Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N. Engl. J. Med. 362(6), 485-493 (2010).
5. Biro FM, Wien M. Childhood obesity and adult morbidities. Am. J. Clin. Nutr. 91(5), 1499SY1505S (2010).
6. Arslanian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: Is 'syndrome X' present? J. Clin. Endocrinol. Metab. 81(3), 1058-1062 (1996).
7. I'Allemand D, Wiegand S, Reinehr T et al.; APV-Study Group. Cardiovascular risk in 26,008 European overweight children as established by a multicenter database. Obesity (Silver Spring) 16(7), 1672-1679 (2008).
8. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: Public-health crisis, common sense cure. Lancet 360(9331), 473-482 (2002).
9. Chu NF, Rimm EB, Wang DJ, Liou HS, Shieh SM. Clustering of cardiovascular disease risk factors among obese schoolchildren: The Taipei Children Heart Study. Am. J. Clin. Nutr. 67(6), 1141-1146 (1998).
10. Csábi G, Török K, Jeges S, Molnár D. Presence of metabolic cardiovascular syndrome in obese children. Eur. J. Pediatr. 159(1-2), 91-94 (2000).
11. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. Pediatrics 103(6 Pt 1), 1175-1182 (1999).
12. Sinha R, Fisch G, Teague B et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N. Engl. J. Med. 346(11), 802-810 (2002).
13. Schober E, Holl RW, Grabert M et al. Diabetes mellitus Type 2 in childhood and adolescence in Germany and parts of Austria. Eur. J. Pediatr. 164(11), 705-707 (2005).
14. American Diabetes Association. Type 2 diabetes in children and adolescents. Diab. Care 23(3), 381-389 (2000).
15. Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch. Dis. Child. 90(1), 10-14 (2005).
16. Weiss R, Dziura J, Burgert TS et al. Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med. 350(23), 2362-2374 (2004).
17. Sinaiko AR, Steinberger J, Moran A, Hong CP, Prineas RJ, Jacobs DR Jr. Influence of insulin resistance and body mass index at age 13 on systolic blood pressure, triglycerides, and high-density lipoprotein cholesterol at age 19. Hypertension 48(4), 730-736 (2006).
18. Reinehr T, Toschke AM. Onset of puberty and cardiovascular risk factors in untreated obese children and adolescents: A 1-year follow-up study. Arch. Pediatr. Adolesc. Med. 163(8), 709-715 (2009).
19. Kleber M, Lass N, Papcke S, Wabitsch M, Reinehr T. One-year follow-up of untreated obese white children and adolescents with impaired glucose tolerance: high conversion rate to normal glucose tolerance. Diabet. Med. 27(5), 516-521 (2010).
20. August GP, Caprio S, Fennoy I et al.; Endocrine Society. Prevention and treatment of pediatric obesity: An endocrine society clinical practice guideline based on expert opinion. J. Clin. Endocrinol. Metab. 93(12), 4576-4599 (2008).
21. Mauras N, Delgiorno C, Kollman C et al. Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J. Clin. Endocrinol. Metab. 95(3), 1060-1068 (2010).
22. Fritsch P, Kleber M, Rosenkranz A et al. Haemostatic alterations in overweight children: Associations between metabolic syndrome, thrombin generation, and fibrinogen levels. Atherosclerosis 212(2), 650-655 (2010).
23. Schulze Horn C, Ilg R, Sander K et al. High-sensitivity C-reactive protein at different stages of atherosclerosis: Results of the INVADE study. J. Neurol. 256(5), 783-791 (2009).
24. Ridker PM, Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J. Periodontol. 79(SUPPL. 8), 1544-1551 (2008).
25. Kynde I, Heitmann BL, Bygbjerg IC, Andersen LB, Helge JW. Hypoadiponectinemia in overweight children contributes to a negative metabolic risk profile 6 years later. Metab. Clin. Exp. 58(12), 1817-1824 (2009).
26. Reinehr T, Stoffel-Wagner B, Roth CL. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. J. Clin. Endocrinol. Metab. 93(6), 2287-2293 (2008).
27. Aeberli I, Biebinger R, Lehmann R, L'allemand D, Spinas GA, Zimmermann MB. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J. Clin. Endocrinol. Metab. 92(11), 4359-4365 (2007).
28. Yeste D, Vendrell J, Tomasini R et al. Retinol-binding protein 4 levels in obese children and adolescents with glucose intolerance. Horm. Res. Paediatr. 73(5), 335-340 (2010).
29. Reinehr T, Woelfle J, Wunsch R, Roth CL. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: A longitudinal analysis. J. Clin. Endocrinol. Metab. 97(6), 2143-2150 (2012).
30. Toschke AM, Reinehr T. Different anthropometric index changes in relation to cardiovascular risk profile change. Clin. Nutr. 27(3), 457-463 (2008).
31. Després JP. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 9(5), 452-459 (1993).
32. Reaven GM. Insulin resistance and compensatory hyperinsulinemia: Role in hypertension, dyslipidemia, and coronary heart disease. Am. Heart J. 121(4 Pt 2), 1283-1288 (1991).
33. Khoury M, Manlhiot C, Dobbin S et al. Role of waist measures in characterizing the lipid and blood pressure assessment of adolescents classified by body mass index. Arch. Pediatr. Adolesc. Med. 166(8), 719-724 (2012).
34. Goran MI, Gower BA. Relation between visceral fat and disease risk in children and adolescents. Am. J. Clin. Nutr. 70(1), 149SY156S (1999).
35. Taylor RW, Jones IE, Williams SM, Goulding A. Evaluation of waist circumference, waist-to-hip ratio, and the conicity index as screening tools for high trunk fat mass, as measured by dual-energy x-ray absorptiometry, in children aged 3-19 y. Am. J. Clin. Nutr. 72(2), 490-495 (2000).
36. Seidell JC, Bakker CJ, van der Kooy K. Imaging techniques for measuring adipose-tissue distribution-A comparison between computed tomography and 1.5-T magnetic resonance. Am. J. Clin. Nutr. 51(6), 953-957 (1990).
37. Armellini F, Zamboni M, Robbi R et al. Total and intra-Abdominal fat measurements by ultrasound and computerized tomography. Int. J. Obes. Relat. Metab. Disord. 17(4), 209-214 (1993).
38. Armellini F, Zamboni M, Rigo L et al. The contribution of sonography to the measurement of intra-Abdominal fat. J. Clin. Ultrasound 18(7), 563-567 (1990).
39. Stolk RP, Meijer R, Mali WP, Grobbee DE, van der Graaf Y; Secondary Manifestations of Arterial Disease Study Group. Ultrasound measurements of intra-Abdominal fat estimate the metabolic syndrome better than do measurements of waist circumference. Am. J. Clin. Nutr. 77(4), 857-860 (2003).
40. Tornaghi G, Raiteri R, Pozzato C et al. Anthropometric or ultrasonic measurements in assessment of visceral fat? A comparative study. Int. J. Obes. Relat. Metab. Disord. 18(11), 771-775 (1994).
41. Armellini F, Zamboni M, Rigo L et al. Measurements of intra-Abdominal fat by ultrasound and computed tomography: Predictive equations in women. Basic Life Sci. 60, 75-77 (1993).
42. Armellini F, Zamboni M, Rigo L et al. Sonography detection of small intra-Abdominal fat variations. Int. J. Obes. 15(12), 847-852 (1991).
43. Bellisari A, Roche AF, Siervogel RM. Reliability of B-mode ultrasonic measurements of subcutaneous adipose tissue and intra-Abdominal depth: Comparisons with skinfold thicknesses. Int. J. Obes. Relat. Metab. Disord. 17(8), 475-480 (1993).
44. Liem ET, De Lucia Rolfe E, L'Abée C, Sauer PJ, Ong KK, Stolk RP. Measuring abdominal adiposity in 6 to 7-year-old children. Eur. J. Clin. Nutr. 63(7), 835-841 (2009).
45. van der Kooy K, Leenen R, Deurenberg P, Seidell JC, Westerterp KR, Hautvast JG. Changes in fat-free mass in obese subjects after weight loss: A comparison of body composition measures. Int. J. Obes. Relat. Metab. Disord. 16(9), 675-683 (1992).
46. Reinehr T, Wunsch R. Relationships between cardiovascular risk profile, ultrasonographic measurement of intra-Abdominal adipose tissue, and waist circumference in obese children. Clin. Nutr. 29(1), 24-30 (2010).
47. Barlow SE, Dietz WH. Management of child and adolescent obesity: Summary and recommendations based on reports from pediatricians, pediatric nurse practitioners, and registered dietitians. Pediatrics 110(1 Pt 2), 236-238 (2002).
48. Reinehr T, Wabitsch M, Andler W et al.; APV Study Group. Medical care of obese children and adolescents. APV: A standardised multicentre documentation derived to study initial presentation and cardiovascular risk factors in patients transferred to specialised treatment institutions. Eur. J. Pediatr. 163(6), 308-312 (2004).
49. Reinehr T, Hoffmeister U, Mann R et al. Medical care of overweight children under real-life conditions: The German BZgA observation study. Int. J. Obes. (Lond.) 33(4), 418-423 (2009).
50. Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24(4), 683-689 (2001).
51. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 105(23), 2696-2698 (2002).
52. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 365(9468), 1415-1428 (2005).
53. Reinehr T, de Sousa G, Toschke AM, Andler W. Comparison of metabolic syndrome prevalence using eight different definitions: A critical approach. Arch. Dis. Child. 92(12), 1067-1072 (2007).
54. Brambilla P, Lissau I, Flodmark CE et al. Metabolic risk-factor clustering estimation in children: To draw a line across pediatric metabolic syndrome. Int. J. Obes. (Lond.) 31(4), 591-600 (2007).
55. Kahn R, Buse J, Ferrannini E, Stern M; American Diabetes Association; European Association for the Study of Diabetes. The metabolic syndrome: Time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care 28(9), 2289-2304 (2005).
56. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-A new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 23(5), 469-480 (2006).
57. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285(19), 2486-2497 (2001).
58. Zimmet P, Alberti KG, Kaufman F et al.; IDF Consensus Group. The metabolic syndrome in children and adolescents-An IDF consensus report. Pediatr. Diabetes 8(5), 299-306 (2007).
59. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: Findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch. Pediatr. Adolesc. Med. 157(8), 821-827 (2003).
60. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet. Med. 19(7), 527-534 (2002).
61. Genuth S, Alberti KG, Bennett P et al.; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26(11), 3160-3167 (2003).
62. Reinehr T, de Sousa G, Andler W. Longitudinal analyses among overweight, insulin resistance, and cardiovascular risk factors in children. Obes. Res. 13(10), 1824-1833 (2005).
63. Allard P, Delvin EE, Paradis G et al. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Québec children and adolescents. Clin. Chem. 49(4), 644-649 (2003).
64. Sattar N, McConnachie A, Shaper AG et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 371(9628), 1927-1935 (2008).
65. Mente A, Yusuf S, Islam S et al.; INTERHEART Investigators. Metabolic syndrome and risk of acute myocardial infarction a caseYcontrol study of 26,903 subjects from 52 countries. J. Am. Coll. Cardiol. 55(21), 2390-2398 (2010).
66. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: A bad idea. Stat. Med. 25(1), 127-141 (2006).
67. Halcox JP, Donald AE, Ellins E et al. Endothelial function predicts progression of carotid intima-media thickness. Circulation 119(7), 1005-1012 (2009).
68. Koskinen J, Kähönen M, Viikari JS et al. Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: The cardiovascular risk in young Finns study. Circulation 120(3), 229-236 (2009).
69. Duprez DA, Somasundaram PE, Sigurdsson G, Hoke L, Florea N, Cohn JN. Relationship between C-reactive protein and arterial stiffness in an asymptomatic population. J. Hum. Hypertens. 19(7), 515-519 (2005).
70. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimalYmedial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study. Circulation 104(23), 2815-2819 (2001).
71. Hurwitz Eller N, Netterstrøm B. The intima-media thickness and coronary risk factors. Int. Angiol. 20(2), 118-125 (2001).
72. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-Analysis. Circulation 115(4), 459-467 (2007).
73. Kasami R, Kaneto H, Katakami N et al. Relationship between carotid intima-media thickness and the presence and extent of coronary stenosis in Type 2 diabetic patients with carotid atherosclerosis but without history of coronary artery disease. Diabetes Care 34(2), 468-470 (2011).
74. Suh SY, Han SW, Kim SH, Kim HJ, Chung SM, Ryu KH. Carotid intima-media thickness and plaque as a predictor for ischemic etiology in patients with severe left ventricular systolic dysfunction. Korean Circ. J. 40(12), 665-670 (2010).
75. Wong M, Edelstein J, Wollman J, Bond MG. UltrasonicYpathological comparison of the human arterial wall. Verification of intima-media thickness. Arterioscler. Thromb. 13(4), 482-486 (1993).
76. Wunsch R, Dudwiesus H, Reinehr T Prospective comparison of different ultrasound modalities to measure thicknesses less than 1 mm. Rofo. 179(1), 65-71 (2007).
77. Reinehr T, Kiess W, de Sousa G, Stoffel-Wagner B, Wunsch R. Intima-media thickness in childhood obesity: Relations to inflammatory marker, glucose metabolism, and blood pressure. Metab. Clin. Exp. 55(1), 113-118 (2006).
78. Wunsch R, de Sousa G, Toschke AM, Reinehr T. Intima-media thickness in obese children before and after weight loss. Pediatrics 118(6), 2334-2340 (2006).
79. Mittelman SD, Gilsanz P, Mo AO, Wood J, Dorey F, Gilsanz V. Adiposity predicts carotid intima-media thickness in healthy children and adolescents. J. Pediatr. 156(4), 592-597.e2 (2010).
80. Short KR, Blackett PR, Gardner AW, Copeland KC. Vascular health in children and adolescents: Effects of obesity and diabetes. Vasc. Health Risk Manag. 5, 973-990 (2009).
81. Wunsch R, de Sousa G, Reinehr T. Intima-media thickness in obesity: Relation to hypertension and dyslipidaemia. Arch. Dis. Child. 90(10), 1097 (2005).
82. Glowinska-Olszewska B, Tolwinska J, Urban M. Relationship between endothelial dysfunction, carotid artery intima-media thickness and circulating markers of vascular inflammation in obese hypertensive children and adolescents. J. Pediatr. Endocrinol. Metab. 20(10), 1125-1136 (2007).
83. Litwin M, Trelewicz J, Wawer Z et al. Intima-media thickness and arterial elasticity in hypertensive children: Controlled study. Pediatr. Nephrol. 19(7), 767-774 (2004).
84. Sorof JM, Alexandrov AV, Cardwell G, Portman RJ. Carotid artery intimalYmedial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 111(1), 61-66 (2003).
85. Lande MB, Carson NL, Roy J, Meagher CC. Effects of childhood primary hypertension on carotid intima-media thickness: A matched controlled study. Hypertension 48(1), 40-44 (2006).
86. Lavrencic A, Kosmina B, Keber I, Videcnik V, Keber D. Carotid intima-media thickness in young patients with familial hypercholesterolaemia. Heart 76(4), 321-325 (1996).
87. Guardamagna O, Abello F, Saracco P, Baracco V, Rolfo E, Pirro M. Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia. Atherosclerosis 207(2), 471-475 (2009).
88. Noto N, Okada T, Yoshino Y, Harada K. B-flow sonographic demonstration for assessing carotid atherosclerosis in young patients with heterozygous familial hypercholesterolemia. J. Clin. Ultrasound 34(2), 43-49 (2006).
89. Rubba P, Iannuzzi A, Faccenda F, De Leo F, Pauciullo P. Noninvasive vascular detection of early signs of atherosclerosis in hypercholesterolemic children: why and how. Nutr. Metab. Cardiovasc. Dis. 11(SUPPL. 5), 10-15 (2001).
90. Krebs A, Schmidt-Trucksäss A, Alt J et al. Synergistic effects of elevated systolic blood pressure and hypercholesterolemia on carotid intima-media thickness in children and adolescents. Pediatr. Cardiol. 30(8), 1131-1136 (2009).
91. Hunt KJ, Williams K, Rivera D et al. Elevated carotid artery intima-media thickness levels in individuals who subsequently develop Type 2 diabetes. Arterioscler. Thromb. Vasc. Biol. 23(10), 1845-1850 (2003).
92. Reinehr T, Wunsch R, de Sousa G, Toschke AM. Relationship between metabolic syndrome definitions for children and adolescents and intima-media thickness. Atherosclerosis 199(1), 193-200 (2008).
93. Urbina EM, Kimball TR, McCoy CE, Khoury PR, Daniels SR, Dolan LM. Youth with obesity and obesity-related Type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function. Circulation 119(22), 2913-2919 (2009).
94. de Sousa G, Brodoswki C, Kleber M, Wunsch R, Reinehr T. Association between androgens, intima-media thickness and the metabolic syndrome in obese adolescent girls. Clin. Endocrinol. (Oxf.) 72(6), 770-774 (2010).
95. Raitakari OT, Juonala M, Viikari JS. Obesity in childhood and vascular changes in adulthood: Insights into the Cardiovascular Risk in Young Finns Study. Int. J. Obes. (Lond.) 29(SUPPL. 2), S101-S104 (2005).
96. Simsek E, Balta H, Balta Z, Dallar Y. Childhood obesity-related cardiovascular risk factors and carotid intima-media thickness. Turk. J. Pediatr. 52(6), 602-611 (2010).
97. Berenson GS. Childhood risk factors predict adult risk associated with subclinical cardiovascular disease. The Bogalusa Heart Study. Am. J. Cardiol. 90(10C), 3LY7L (2002).
98. Freedman DS, Patel DA, Srinivasan SR et al. The contribution of childhood obesity to adult carotid intima-media thickness: The Bogalusa Heart Study. Int. J. Obes. (Lond.) 32(5), 749-756 (2008).
99. Juonala M, Viikari JS, Kähönen M et al. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: The Cardiovascular Risk in Young Finns Study. J. Am. Coll. Cardiol. 52(4), 293-299 (2008).
100. Cheng DC, Schmidt-Trucksäss A, Cheng KS, Burkhardt H. Using snakes to detect the intimal and adventitial layers of the common carotid artery wall in sonographic images. Comput. Methods Programs Biomed. 67(1), 27-37 (2002).
101. Schmidt-Trucksäss A, Cheng DC, Sandrock M et al. Computerized analysing system using the active contour in ultrasound measurement of carotid artery intima-media thickness. Clin. Physiol. 21(5), 561-569 (2001).
102. Bots ML, Hofman A, Grobbee DE. Increased common carotid intima-media thickness. Adaptive response or a reflection of atherosclerosis? Findings from the Rotterdam Study. Stroke 28(12), 2442-2447 (1997).
103. Corretti MC, Anderson TJ, Benjamin EJ et al.; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelialdependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 39(2), 257-265 (2002).
104. Meyer AA, Kundt G, Steiner M, Schuff-Werner P, Kienast W. Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: The impact of cardiovascular risk factors. Pediatrics 117(5), 1560-1567 (2006).
105. Arnett DK, Evans GW, Riley WA. Arterial stiffness: A new cardiovascular risk factor? Am. J. Epidemiol. 140(8), 669-682 (1994).
106. Riggio S, Mandraffino G, Sardo MA et al. Pulse wave velocity and augmentation index, but not intima-media thickness, are early indicators of vascular damage in hypercholesterolemic children. Eur. J. Clin. Invest. 40(3), 250-257 (2010).
107. Summerbell CD, Ashton V, Campbell KJ, Edmunds L, Kelly S, Waters E. Interventions for treating obesity in children. Cochrane Database Syst. Rev. 3, CD001872 (2003).
108. Oude Luttikhuis H, Baur L, Jansen H et al. Interventions for treating obesity in children. Cochrane Database Syst. Rev. 1, CD001872 (2009).
109. Okely AD, Collins CE, Morgan PJ et al. Multi-site randomized controlled trial of a child-centered physical activity program, a parent-centered dietary-modification program, or both in overweight children: The HIKCUPS study. J. Pediatr. 157(3), 388-94, 394.e1 (2010).
110. Kalarchian MA, Levine MD, Arslanian SA et al. Family-based treatment of severe pediatric obesity: Randomized, controlled trial. Pediatrics 124(4), 1060-1068 (2009).
111. Reinehr T, Kiess W, Kapellen T, Andler W. Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics 114(6), 1569-1573 (2004).
112. Reinehr T, Andler W. Changes in the atherogenic risk factor profile according to degree of weight loss. Arch. Dis. Child. 89(5), 419-422 (2004).
113. Reinehr T, Kleber M, Toschke AM. Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence. Atherosclerosis 207(1), 174-180 (2009).
114. Reinehr T, Roth C, Menke T, Andler W. Adiponectin before and after weight loss in obese children. J. Clin. Endocrinol. Metab. 89(8), 3790-3794 (2004).
115. Reinehr T, Stoffel-Wagner B, Roth CL, Andler W. High-sensitive C-reactive protein, tumor necrosis factor α, and cardiovascular risk factors before and after weight loss in obese children. Metab. Clin. Exp. 54(9), 1155-1161 (2005).
116. Reinehr T, Roth CL. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J. Clin. Endocrinol. Metab. 93(11), 4479-4485 (2008).
117. Roth CL, Kratz M, Ralston MM, Reinehr T. Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metab. Clin. Exp. 60(4), 445-452 (2011).
118. Farpour-Lambert NJ, Aggoun Y, Marchand LM, Martin XE, Herrmann FR, Beghetti M. Physical activity reduces systemic blood pressure and improves early markers of atherosclerosis in pre-pubertal obese children. J. Am. Coll. Cardiol. 54(25), 2396-2406 (2009).
119. Meyer AA, Kundt G, Lenschow U, Schuff-Werner P, Kienast W. Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program. J. Am. Coll. Cardiol. 48(9), 1865-1870 (2006).
120. Iannuzzi A, Licenziati MR, Vacca M et al. Comparison of two diets of varying glycemic index on carotid subclinical atherosclerosis in obese children. Heart Vessels 24(6), 419-424 (2009).
121. Kelishadi R, Hashemi M, Mohammadifard N, Asgary S, Khavarian N. Association of changes in oxidative and proinflammatory states with changes in vascular function after a lifestyle modification trial among obese children. Clin. Chem. 54(1), 147-153 (2008).
122. Reinehr T, Widhalm K, l'Allemand D, Wiegand S, Wabitsch M, Holl RW; APV-Wiss STudy Group and German Competence Net Obesity. Two-year follow-up in 21,784 overweight children and adolescents with lifestyle intervention. Obesity (Silver Spring) 17(6), 1196-1199 (2009).
123. Denzer C, Reithofer E, Wabitsch M, Widhalm K. The outcome of childhood obesity management depends highly upon patient compliance. Eur. J. Pediatr. 163(2), 99-104 (2004).
124. Pinelli L, Elerdini N, Faith MS et al. Childhood obesity: Results of a multicenter study of obesity treatment in Italy. J. Pediatr. Endocrinol. Metab. 12(SUPPL. 3), 795-799 (1999).
125. Grinstein G, Muzumdar R, Aponte L, Vuguin P, Saenger P, DiMartino-Nardi J. Presentation and 5-year follow-up of Type 2 diabetes mellitus in African-American and CaribbeanYHispanic adolescents. Horm. Res. 60(3), 121-126 (2003).
126. Reinehr T, Schober E, Roth CL, Wiegand S, Holl R; DPV-Wiss Study Group. Type 2 diabetes in children and adolescents in a 2-year follow-up: Insufficient adherence to diabetes centers. Horm. Res. 69(2), 107-113 (2008).
127. Reinehr T, Wiegand S, Siegfried W et al. Comorbidities in overweight children and adolescents: Do we treat them effectively? Int. J. Obes. (Lond.) doi:10.1038/ijo.2012.184 (2012) (Epub ahead of print).
128. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: Findings from the Third National Health and Nutrition Examination Survey. Circulation 110(16), 2494-2497 (2004).